TY  - GEN
AU  - Diodati,J G
AU  - Saucedo,J F
AU  - Cardillo,T E
AU  - Jakubowski,J A
AU  - Henneges,C
AU  - Effron,M B
AU  - Lipkin,F R
AU  - Walker,J R
AU  - Duvvuru,S
AU  - Sundseth,S S
AU  - Fisher,H N
AU  - Angiolillo,D J
TI  - Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients. High on-treatment platelet reactivity analysis of the TRIPLET trial
SN  - 2567-689X
PY  - 2015///1015
KW  - Acute Coronary Syndrome
KW  - blood
KW  - Aged
KW  - Blood Platelets
KW  - drug effects
KW  - Clopidogrel
KW  - Cytochrome P-450 CYP2C19
KW  - genetics
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Drug Resistance
KW  - Drug Substitution
KW  - Female
KW  - Genotype
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Percutaneous Coronary Intervention
KW  - adverse effects
KW  - Phenotype
KW  - Piperazines
KW  - administration & dosage
KW  - Platelet Aggregation Inhibitors
KW  - Platelet Function Tests
KW  - Prasugrel Hydrochloride
KW  - Thiophenes
KW  - Ticlopidine
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1160/TH13-09-0747
ER  -